Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,622 | -166,014 | -110,936 | -84,409 | -50,317 |
| Depreciation Amortization | 331 | 1,172 | 810 | 533 | 260 |
| Accounts payable and accrued liabilities | 359 | -7,804 | -3,217 | 6,212 | 2,544 |
| Other Working Capital | -4,997 | 18,518 | -9,813 | -2,169 | 2,036 |
| Other Operating Activity | 1,744 | 65,738 | 20,054 | 5,541 | 4,538 |
| Operating Cash Flow | $-20,185 | $-88,390 | $-103,102 | $-74,292 | $-40,939 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,900 | -20,619 | -18,310 | -16,290 | -8,427 |
| Purchase Sale Intangibles | N/A | -4,250 | -4,250 | -3,250 | -3,000 |
| Other Investing Activity | 0 | -4,311 | -4,250 | -3,250 | -3,000 |
| Investing Cash Flow | $-3,900 | $-24,930 | $-22,560 | $-19,540 | $-11,427 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 50 | 41,857 | 11,893 | 11,961 | 277 |
| Other Financing Activity | -420 | 10,240 | -1,028 | -993 | -384 |
| Financing Cash Flow | $-370 | $52,097 | $10,865 | $10,968 | $-107 |
| Beginning Cash Position | 90,517 | 151,740 | 151,740 | 151,740 | 151,740 |
| End Cash Position | 66,062 | 90,517 | 36,943 | 68,876 | 99,267 |
| Net Cash Flow | $-24,455 | $-61,223 | $-114,797 | $-82,864 | $-52,473 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,185 | -88,390 | -103,102 | -74,292 | -40,939 |
| Capital Expenditure | -3,900 | -20,619 | -18,310 | -16,290 | -8,427 |
| Free Cash Flow | -24,085 | -109,009 | -121,412 | -90,582 | -49,366 |